ONCTERNAL THERAPEUTICS INC (ONCT)
US68236P2065 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ONCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.28. This target is 256.87% above the current price.
ONCT was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ONCT.
In the previous month the buy percentage consensus was at a similar level.
ONCT was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-04 | Brookline Capital | Upgrade | Hold -> Buy |
| 2023-09-18 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-04-04 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-04-04 | Brookline Capital | Downgrade | Buy -> Hold |
| 2023-04-04 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-04-04 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-04-04 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-03-22 | Oppenheimer | Maintains | Outperform |
| 2023-03-14 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-10 | Maxim Group | Initiate | Buy |
| 2022-02-24 | BTIG | Initiate | Buy |
| 2021-04-07 | Oppenheimer | Initiate | Outperform |
| 2021-03-30 | Brookline Capital | Initiate | Buy |
| 2021-03-12 | HC Wainwright & Co. | Maintains | Buy |